Here are 18 key notes on orthopedic and spine device companies from the past week.
Mazor reported $11.7 million in revenue for the first quarter of 2017.
Alphatec Holdings' first quarter revenues dropped 19.8 percent compared with the same period last year.
Xtant Medical reported first quarter 2017 revenue of $22.1 million.
Xtant Medical announced OrbiMed financing as well as an agreement with Aurora Management Partners.
IZI Medical Products acquired Cook Medical's vertebroplasty product portfolio.
Medtronic Vice President for Global Regulatory Affairs Pat Shrader urged Congress to improve medical device manufacturing facility inspections.
Conventus Orthopaedics raised $20 million to fund and commercialize fracture repair therapies.
InVivo Therapeutics enrolled a new patient in its INSPIRE Study, bringing the study's total nationwide enrollment to 15 patients.
Vertebral Technologies received a new patent grant titled, "Methods and Apparatus for Minimally Invasive Modular Interbody Fusion Devices."
Cincinnati-based Mayfield Brain & Spine neurosurgeons implanted the first Senza SCS system by Nevro in the region.
Jason Rosenberg, MD, of South Carolina Pain & Spine Specialists is the first physician in South Carolina to implant Nuvectra's Algovita Spinal Cord Stimulation System in patients.
Surgeons at Mobile-based Alabama Orthopaedic Clinic and Mobile-based Springhill Hospital are the first providers in Mobile to use Stryker's Mako Robotic Arm device.
Fort Walton Beach (Fla.) Medical Center began treating patients with Stryker's Mako Robotic Arm Assisted Procedures.
Titan Spine hired Ed Graubart to serve as its vice president of professional development.
OrthAlign named Andy Turner country director of Australia and New Zealand.
Mainstay Medical launched commercialization of its ReActiv8 device in Ireland.
OrthoSpace began enrolling patients in a study of its InSpace System.
Histogenics received a 2017 New England Innovation award sponsored by Waltham-based Smaller Business Association of New England.